|drug3683||Specific anti-SARS-CoV-2 antibodies Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
Assess the impact of a proprietary extract of Nerium oleander on COVID-19 symptoms and mortality in COVID-19 positive patients and their close contacts compared to controls that did not receive the extract.
Description: The CDC list of symptoms and "other".Measure: COVID19 symptoms Time: Every 6 hours for 10 days
Description: A patient in any arm that dies.Measure: Mortality Time: 10 days from enrollment into the Study, e.g. Day 10
Description: COVID19 Live Virus Nasopharyngeal swab performed by UTMB, TexasMeasure: COVID19 Live Virus Time: Day 1, Day 5, Day 10
Description: RT-PCR Nasopharyngeal swab performed by Fulgent, CaliforniaMeasure: RT-PCR COVID19 Test Time: Day 1, Day 5, Day 10
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports